Landscapes / Targets

IL-17A

12 drugs act on IL-17A, in 33 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs12

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Approved 21 Dec 2026Phase 3 trial completes
—
3SBio · Public 1530.HK
Approved in China 14 Jan 2027Phase 3 trial completes
Monoclonal antibody
Hengrui · Public 600276.SS
Approved in China Mar 2027Phase 4 trial completes
Monoclonal antibody
Approved 8 Feb 2028Phase 4 trial completes
Monoclonal antibody
Eli Lilly · Public LLY
Approved —
Monoclonal antibody
Phase 3 4 Jan 2027Phase 3 trial completes
—
Sinocelltech · Public 688520.SS
Phase 2 12 Mar 2027Phase 2 trial completes
Multi-specific immunoglobulin
Phase 2 17 May 2027Phase 2 trial completes
—
Huahai Pharmaceutical (Huaota) · Public 600521.SS
Phase 1/2 —
SB35not checked
—
Phase 1 9 Jun 2027Phase 1 trial completes
—
Akeso · Public 9926.HK
Phase 1 —
CT-P52not checked
—
Phase 1 —

About this list

Checked
10 of 12 drugs. The other 2 are marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IL-17A

Following is part of Solo: you see every change to IL-17A the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in